Evidence map›Paper›PMID 38397081›Full record

ArticleInternational journal of molecular sciences2024

Aryl Hydrocarbon Receptor Regulates Muc2 Production Independently of IL-22 during Colitis.

Archana Saxena, Chandani Mitchell, Raymond Bogdon, Kasie Roark, Kiesha Wilson, Shanieka Staley, Michelle Hailey, Michal Claire Williams, Alex Rutkovsky, Prakash Nagarkatti and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The aryl hydrocarbon receptor: a new frontier in male reproductive system.Reproductive biology and endocrinology : RB&E · 2025
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Regulation ofFrontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Archana SaxenaDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0003-3490-0181
Chandani MitchellDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Raymond BogdonDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Kasie RoarkDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Kiesha WilsonDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0001-8550-3739
Shanieka StaleyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Michelle HaileyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Michal Claire WilliamsDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Alex RutkovskyDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
Prakash NagarkattiDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0003-2663-0759
Mitzi NagarkattiDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-5977-5615
Philip Brandon BusbeeDepartment of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.ORCID 0000-0002-7029-2403
University of South Carolina · US

Funding

Targeting early ceramide elevation in pre-symptomatic eczemaP20GM103641 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ENOS, REILLY, NAGARKATTI, PRAKASH S · 2012 to 2023
$20.7M
Role of the environmental sensor, AhR on colitisR01AI160896 · NIAID · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2021 to 2025
$2.6M
Epigenetic mechanisms in Transgenerational Effects of an Environmental PollutantR01ES030144 · NIEHS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI NAGARKATTI, MITZI, NAGARKATTI, PRAKASH S · 2019 to 2023
$2.5M
Role of Macrophages in CBD mediated attenuation of SEB-induced ARDSR00GM147910 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI WILSON, KIESHA · 2023 to 2025
$747k
NIAID NIH HHS R01 AI160896NIEHS NIH HHS R01 ES030144NIGMS NIH HHS P20 GM103641NIGMS NIH HHS R00 GM147910NIH HHS P20GM103641NIH HHS R01AI160896NIH HHS R01ES030144
6 · The paper itself

Abstract

We previously reported that an aryl hydrocarbon receptor (AhR) ligand, indole-3-carbinol (I3C), was effective at reducing colitis severity through immune cell-mediated interleukin-22 (IL-22) production. Intestinal epithelial cells (IECs) are also involved in regulating colitis, so we investigated their AhR-mediated mechanisms in the current report. A transcriptome analysis of IECs in wildtype (WT) mice revealed that during colitis, I3C regulated select mucin proteins, which could be attributed to goblet cell development. To address this, experiments under in vivo colitis (mice) or in vitro colon organoid conditions were undertaken to determine how select mucin proteins were altered in the absence or presence of AhR in IECs during I3C treatment. Comparing WT to IEC-specific AhR knockout mice (AhR

Indexed as

ColitisReceptors, Aryl HydrocarbonAnimalsInterleukin-22MiceMice, Inbred C57BLMucin-2MucinsInterleukin-22Muc2 protein, mouseMucin-2MucinsReceptors, Aryl Hydrocarbonaryl hydrocarbon receptorcolitisgoblet cellindole-3-carbinolinflammatory bowel diseaseinterleukin-22mucin

Identifiers

PMID38397081
PMCPMC10888603
OpenAlexW4391946611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.